Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
16 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Dostarlimab“
Suchtreffer
Begriffe & Kennungen
Jemperli · 4.5 · No interaction studies have been performed. Monoclonal antibodies (mAb) such as dostarlimab are not substrates
Eintrag öffnenJemperli · 4.8 · 11 Dostarlimab monotherapy Dostarlimab in combination with chemotherapy Uncommon Type 1 diabetes mellitus, dia
Eintrag öffnenJemperli · 4.8 · Adverse reactions known to occur with dostarlimab as monotherapy, or with carboplatin or paclitaxel given alon
Eintrag öffnenJemperli · 4.8 · Adverse reactions reported in clinical trials of dostarlimab as a monotherapy or in combination with chemother
Eintrag öffnenJemperli · 4.8 · Dostarlimab in combination with carboplatin and paclitaxel
Eintrag öffnenJemperli · 4.8 · Dostarlimab in monotherapy
Eintrag öffnenJemperli · 4.8 · Dostarlimab is most commonly associated with immune-related adverse reactions. Most of these, including severe
Eintrag öffnenJemperli · 4.8 · In the GARNET study, anti-drug antibodies (ADA) were tested in 315 patients who received dostarlimab and the i
Eintrag öffnenJemperli · 4.8 · In the patients who developed ADAs, there was no evidence of altered efficacy or safety of dostarlimab.
Eintrag öffnenJemperli · 4.8 · Of the 605 patients treated with dostarlimab monotherapy, 51.6 % were under 65 years, 36.9 % were 65 to less t
Eintrag öffnenJemperli · 4.8 · Table 4: Adverse reactions in patients treated with dostarlimab Dostarlimab monotherapy Dostarlimab in combina
Eintrag öffnenJemperli · 4.8 · The safety of dostarlimab has been evaluated in 241 patients with primary advanced or recurrent EC who receive
Eintrag öffnenJemperli · 4.8 · The safety of dostarlimab has been evaluated in 605 patients with EC or other advanced solid tumours who recei
Eintrag öffnenJemperli · 4.8 · The selected adverse reactions described below are based on the safety of dostarlimab in a combined monotherap
Eintrag öffnendostarlimab
Eintrag öffnendostarlimab
Eintrag öffnen